KRRO - Korro Bio, Inc.
Price:
--
--
|
CONSENSUS:
Buy
DETAILS
|
PRICE TARGET:
$19.57
DETAILS
HIGH:
$30.00
LOW:
$10.00
MEDIAN:
$22.00
CONSENSUS:
$19.57
UPSIDE:
68.56%
About Korro Bio, Inc. (https://www.korrobio.com)
Korro Bio, Inc., a biopharmaceutical company, discovers, develops, and commercializes genetic medicines based on editing RNA for the treatment of rare and highly prevalent diseases. Korro Bio, Inc. is based in Cambridge, Massachusetts.
Key Executives
| NAME | TITLE | DOB | SALARY |
|---|---|---|---|
| Ram Aiyar | Chief Executive Officer, President, Interim Chief Financial Officer, Principal Financial Officer & Director | 1978 | $852,656 USD |
| Loic Vincent | Chief Scientific Officer | – | $642,518 USD |
| Jeffrey Cerio | Senior Vice President, General Counsel & Corporate Secretary | – | $587,500 USD |
| Andrew Fraley | Co-Founder & Advisor | – | – |
| Gaozhong Zhu | SVP of Chemistry, Manufacturing and Controls & Technical Operations | – | – |
| Joshua Rosenthal | Co-Founder & Advisor | – | – |
| Oliver Dolan | Senior Vice President of Finance & Principal Accounting Officer | 1983 | – |
| Stephanie Engels | Chief People Officer | – | – |
| Todd Chappell | Chief Operating Officer | 1973 | – |